TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer March 26, 2010
TCL Archive In Brief: NCI Thinks Puerto Rico Should Have Comprehensive Center; President Says He Won’t Oppose NIH Budget Increases April 26, 1974
TCL Archive NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement June 26, 1987
